In 2004, the Tan team took the lead in developing a parafibromin monoclonal antibody for immunohistochemistry and found that loss of parafibromin immunoreactivity was consistent with somatic HRPT2 gene mutation in sporadic PC [44]. The gene discussed is CDC73; the disease is pachyonychia congenita.